Stock A304360 S.BIOMEDICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company S.Biomedics CO., LTD.

Equities

A304360

KR7304360001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-13 EDT 		5-day change 1st Jan Change
42,100 KRW -4.54% Intraday chart for S.Biomedics CO., LTD. +6.58% +266.09%
2023 S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2023 S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. CI

Business Summary

S Biomedics Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of biopharmaceuticals. The Company operates business through two segments. The Medical Devices segment engages in the manufacture and sale of medical devices and cosmetics. The Stem Cell Therapeutics segment is primarily engaged in the manufacture and sale of stem cell therapies. Additionally, this segment is engaged in stem cell research and development (R&D).

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medical Equipment
99.4 %
12,034 99.3 % 13,029 99.4 % +8.27%
Stem Cell Therapy
2.2 %
361 3.0 % 291 2.2 % -19.46%
Consolidated Adjustment
-1.6 %
-283 -2.3 % -212 -1.6 % -25.06%

Sales per region

KRW in Million2022Weight2023Weight Delta
Foreign
85.6 %
10,386 85.7 % 11,216 85.6 % +7.99%
South Korea
14.4 %
1,727 14.3 % 1,892 14.4 % +9.59%

Managers

Managers TitleAgeSince
Sae-Il Kang CEO
 Chief Executive Officer 44 18-03-28
Dong-Wook Kim CEO
 Chief Executive Officer 63 19-03-30
Myung-Soo Cho CTO
 Chief Tech/Sci/R&D Officer 55 19-03-28
Won-Geun Kim AUD
 Comptroller/Controller/Auditor 71 -

Members of the board

Members of the board TitleAgeSince
Sae-Il Kang CEO
 Chief Executive Officer 44 18-03-28
Dong-Wook Kim CEO
 Chief Executive Officer 63 19-03-30
Myung-Soo Cho CTO
 Chief Tech/Sci/R&D Officer 55 19-03-28
Sang-Heon Kim BRD
 Director/Board Member 57 18-03-29
Jung-Soon Jang BRD
 Director/Board Member 67 19-03-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,427,076 8,023,629 ( 70.22 %) 0 70.22 %

Shareholders

NameEquities%Valuation
Sae-Il Kang
18.06 %
2,063,551 18.06 % 56 M ₩
BINEX CO., LTD.
8.047 %
919,552 8.047 % 25 M ₩
Mirae Equity Partners Co., Ltd.
5.833 %
666,500 5.833 % 18 M ₩
NHN CORPORATION
4.927 %
563,000 4.927 % 15 M ₩
Meritz Financial Securities Co., Ltd.
4.682 %
535,068 4.682 % 14 M ₩
Dong-Wook Kim
3.614 %
413,000 3.614 % 11 M ₩
DONGKOOK PHARMACEUTICAL CO., LTD.
0.9724 %
111,112 0.9724 % 3 M ₩
Jong-wan Kim
0.2605 %
29,764 0.2605 % 806 146 ₩
Myung-Soo Cho
0.0438 %
5,000 0.0438 % 135 423 ₩
Sang-Heon Kim
0.0438 %
5,000 0.0438 % 135 423 ₩

Company contact information

S.Biomedics Co., Ltd.

4F, Wooil Venture Town Building 28, Seongsui-ro 26-gil

04797, Seoul

+

http://www.sbiomedics.com
address S.Biomedics CO., LTD.(A304360)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
S.BIOMEDICS CO., LTD. Stock S.Biomedics CO., LTD.
+266.09% 348M
CSL LIMITED Stock CSL Limited
+0.85% 92.38B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.03% 37.9B
BIOGEN INC. Stock Biogen Inc.
-10.46% 33.73B
UCB Stock UCB
+74.71% 27.98B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-13.39% 15.86B
INCYTE CORPORATION Stock Incyte Corporation
-1.08% 13.97B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.15% 11.67B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+169.04% 10.17B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-50.19% 10.04B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A304360 Stock
  4. Company S.Biomedics CO., LTD.